Teva Pharmaceutical Statistics
Total Valuation
TEVA has a market cap or net worth of $19.35 billion. The enterprise value is $35.63 billion.
Important Dates
The last earnings date was Wednesday, November 6, 2024, before market open.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TEVA has 1.13 billion shares outstanding. The number of shares has increased by 0.87% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.13B |
| Shares Change (YoY) | +0.87% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 69.08% |
| Float | 1.13B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 6.50 |
| PS Ratio | 1.15 |
| Forward PS | 1.17 |
| PB Ratio | 3.19 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.15 |
| P/OCF Ratio | 10.43 |
| PEG Ratio | 26.78 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 7.44, with an EV/FCF ratio of 26.04.
| EV / Earnings | n/a |
| EV / Sales | 2.12 |
| EV / EBITDA | 7.44 |
| EV / EBIT | 9.55 |
| EV / FCF | 26.04 |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 3.02.
| Current Ratio | 0.89 |
| Quick Ratio | 0.49 |
| Debt / Equity | 3.02 |
| Debt / EBITDA | 3.92 |
| Debt / FCF | 14.09 |
| Interest Coverage | 3.69 |
Financial Efficiency
Return on equity (ROE) is -17.52% and return on invested capital (ROIC) is 8.72%.
| Return on Equity (ROE) | -17.52% |
| Return on Assets (ROA) | 5.56% |
| Return on Capital (ROIC) | 8.72% |
| Revenue Per Employee | $443,106 |
| Profits Per Employee | -$25,336 |
| Employee Count | 37,851 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 2.10 |
Taxes
In the past 12 months, TEVA has paid $689.00 million in taxes.
| Income Tax | 689.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +80.74% in the last 52 weeks. The beta is 0.87, so TEVA's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | +80.74% |
| 50-Day Moving Average | 17.70 |
| 200-Day Moving Average | 16.15 |
| Relative Strength Index (RSI) | 44.01 |
| Average Volume (20 Days) | 7,575,436 |
Short Selling Information
| Short Interest | 18.09M |
| Short Previous Month | 24.49M |
| Short % of Shares Out | 1.61% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.50 |
Income Statement
In the last 12 months, TEVA had revenue of $16.77 billion and -$959.00 million in losses. Loss per share was -$0.86.
| Revenue | 16.77B |
| Gross Profit | 8.36B |
| Operating Income | 3.73B |
| Pretax Income | 131.00M |
| Net Income | -959.00M |
| EBITDA | 4.79B |
| EBIT | 3.73B |
| Loss Per Share | -$0.86 |
Full Income StatementBalance Sheet
The company has $3.32 billion in cash and $19.28 billion in debt, giving a net cash position of -$15.96 billion or -$14.08 per share.
| Cash & Cash Equivalents | 3.32B |
| Total Debt | 19.28B |
| Net Cash | -15.96B |
| Net Cash Per Share | -$14.08 |
| Equity (Book Value) | 6.38B |
| Book Value Per Share | 5.35 |
| Working Capital | -1.48B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.86 billion and capital expenditures -$488.00 million, giving a free cash flow of $1.37 billion.
| Operating Cash Flow | 1.86B |
| Capital Expenditures | -488.00M |
| Free Cash Flow | 1.37B |
| FCF Per Share | $1.21 |
Full Cash Flow StatementMargins
Gross margin is 49.84%, with operating and profit margins of 22.24% and -5.72%.
| Gross Margin | 49.84% |
| Operating Margin | 22.24% |
| Pretax Margin | -3.15% |
| Profit Margin | -5.72% |
| EBITDA Margin | 28.54% |
| EBIT Margin | 22.24% |
| FCF Margin | 4.17% |
Dividends & Yields
TEVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.87% |
| Shareholder Yield | -0.87% |
| Earnings Yield | -4.96% |
| FCF Yield | 7.07% |
Dividend DetailsAnalyst Forecast
The average price target for TEVA is $19.63, which is 14.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.63 |
| Price Target Difference | 14.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on July 1, 2004. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 1, 2004 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
TEVA has an Altman Z-Score of 0.42 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.42 |
| Piotroski F-Score | 6 |